No Single Age Fits All: A Neuroscience Approach to Online Child Safety
Australia introduced a world-first law banning children under 16 from accessing social media platforms. The Online Safety Amendment (Social Media Minimum Age), which took effect in December 2025,...
View ArticleAnalyzing Doping, Enhanced Sport, and Enterprise Responsibility
On May 24, 2026, an entity with ties to Peter Thiel, Donald Trump Jr., and Christian Angermayer will apparently offer athletes $250,000 per event won and potential $1 million bonuses to compete in the...
View ArticleClik here to view.
The Growing Use of the FDA Breakthrough Devices Program and Recalls
At the close of 2025, the US Government Accountability Office (GAO) issued a report concluding that the Food and Drug Administration (FDA) should dedicate more resources to its oversight of recalls for...
View ArticleEven Chile’s Neurorights Leave Inferred Mental Data in a Gray Zone
Chile is often described as one of the strongest constitutional examples of neurorights—that is, special legal protection for brain-related information and mental integrity.[1] In 2021, Chile amended...
View ArticleWhy AI Cannot Forget Genomic Data
The right to be forgotten is becoming increasingly difficult to enforce in practice for genomic data trained on Artificial Intelligence (AI) models. Once genomic data is used to train AI models, it...
View ArticleLess Invasion, More Inclusion: IVG’s Potential Impact on Posthumous Gamete...
Posthumous conception remains one of the most contested practices in assisted human reproduction (AHR), with objections often centering on the invasive nature of retrieving gametes from the deceased or...
View ArticleWho Owns Digital Thoughts? The Limits of Property Law and the 2025 UNESCO...
The rapid advancement of Brain–Computer Interfaces (BCIs) and artificial intelligence (AI) in neurotechnology has moved beyond speculative science and clinical experimentation into commercial and...
View ArticleReproductive Due Process: Procedural Justice in an Era of Arbitrariness
I. Introduction: The Invisible Constraint The rapid evolution of reproductive technologies has forced courts and legislatures to confront questions that once seemed purely theoretical. In vitro...
View ArticleNeuroimaging Evidence in Criminal Cases
Imagine you’re a juror in a murder trial. The defense attorney wheels in a large monitor displaying colorful brain scans of the defendant. An expert witness points to areas highlighted in blue and red,...
View ArticleAre Neural Organoids Part of “Neurotechnology”?
November 2025 was a big moment for the governance of two very similar things: neurotechnology and neural organoids. On November 5, the United Nations Educational, Scientific and Cultural Organization...
View ArticleCutting to the core: Down syndrome, CRISPR, and the future of human diversity...
Gabriela Ríos Ríos, SLS LLM and CLB student fellow, 2025 This is the final part of a three part blog post. The first part of this blog post explored the science behind the study published by Hashizume...
View ArticleCutting to the core: Down syndrome, CRISPR, and the future of human diversity...
Gabriela Ríos Ríos, LLM and CLB student fellow, SLS 2025 This is Part II of a three part blog post. As explained in detail in the first part of this blog post, the study published by Hashizume et...
View ArticleCutting to the core: Down syndrome, CRISPR, and the future of human diversity...
By Gabriela Ríos Ríos, SLS LLM and CLB Student Fellow, 2025 This is the first of a three-part blog post. “After decades of concentrated efforts, we are finally learning how to harness natural...
View ArticleGeopolitics and Strategic Competition Behind U.S.-China Genomic Data Policies
GEOPOLITICS AND STRATEGIC COMPETITION BEHIND U.S.-CHINA GENOMIC DATA POLICIES Zijing Yang, Stanford LLM ’25, CLB student fellow A new rule issued by the Department of Justice of the United States (the...
View ArticleIn Vitro Gametogenesis: Reproductive Rights and Non-Discrimination under EU Law
Written by Hanna Engstrom, SLS LLM ’25, CLB student fellow As reproductive technologies evolve, the legal frameworks that govern them will grapple with questions of autonomy, equality, and human...
View ArticleIVG and the EU Morality Clause: Innovation Meets Ethical Guardrails
Written by Hanna Engstrom, SLS LLM ’25, CLB student fellow In vitro gametogenesis (IVG) is the process of creating eggs or sperm from somatic cells, and it is no longer science fiction. Researchers...
View ArticleBrüstle to ISCC: Rethinking “Human Embryo” in EU Patent Law
Post by Hanna Engstrom, SLS LLM ’25, CLB student fellow The European Union’s legal treatment of human embryonic stem cell (hESC) technologies has long stood at the intersection of science, ethics, and...
View ArticleMedical Tourism into Japan: Can Japan Ride the Big Wave?
Shin Koike LLM, student fellow, Center for Law and the Biosciences Introduction Medical tourism—traveling to another country to receive medical care—has multiple layers, making it both complex and...
View ArticleChina’s Drug Reimbursement Transition to Support Innovation
China’s Drug Reimbursement Transition to Support Innovation Zijing Yang, Student Fellow, Stanford LLM 2025 In the previous blog post, I discussed China’s national drug centralized procurement policy...
View ArticleIn the Twilight of Regulation: DTC Genetic Testing and Medical Practice in Japan
Shin Koike (LLM expected 2025), student fellow, Center for Law and the Biosciences Introduction Direct-to-consumer (DTC) genetic testing is now widely available in the United States (U.S.), with over...
View Article
